Notably, insulin receptor levels are visualised easily in three of the four gastric cancer cell lines and in the metastatic cells that represent the majority of gastric cancers that are triple-negative for ERBB2, FGFR2 or MET overexpression [7]. This evidence concerns the gene MET and gastric cancer.